J. Bentham et al., HISTOCHEMICAL DETECTION OF BINDING-SITES FOR HUMAN GROWTH-HORMONE USING BIOTINYLATED LIGAND, The Journal of histochemistry and cytochemistry, 42(1), 1994, pp. 103-107
Recombinant human growth hormone was covalently linked to biotin via a
six-carbon spacer arm. Biotinylation was confirmed by electrophoresis
and mass spectrometry showed that approximately 50% of the hormone wa
s monobiotinylated. The modified growth hormone (GH) was shown to bind
to the GH receptor of IM9 human lymphoid cells with an affinity of 0.
55 x 10(9) M(-1). Bioactivity of biotinylated GH measured in the Nb2 b
ioassay was 53.9% that of unlabeled GH. GH binding sites on human IM9
cells were visualized histochemically with the biotinylated hormone, a
technique that provides a means of identifying receptors for GH on ta
rget cells in vitro.